The Role of Mast Cells in Bone Metabolism and Bone Disorders
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Mast cells (MCs) are important sensor and effector cells of the immune system that are involved in many physiological and pathological conditions. Increasing evidence suggests that they also play an important role in bone metabolism and bone disorders. MCs are located in the bone marrow and secrete a wide spectrum of mediators, which can be rapidly released upon activation of mature MCs following their differentiation in mucosal or connective tissues. Many of these mediators can exert osteocatabolic effects by promoting osteoclast formation [e.g., histamine, tumor necrosis factor (TNF), interleukin-6 (IL-6)] and/or by inhibiting osteoblast activity (e.g., IL-1, TNF). By contrast, MCs could potentially act in an osteoprotective manner by stimulating osteoblasts (e.g., transforming growth factor-β) or reducing osteoclastogenesis (e.g., IL-12, interferon-γ). Experimental studies investigating MC functions in physiological bone turnover using MC-deficient mouse lines give contradictory results, reporting delayed or increased bone turnover or no influence depending on the mouse model used. By contrast, the involvement of MCs in various pathological conditions affecting bone is evident. MCs may contribute to the pathogenesis of primary and secondary osteoporosis as well as inflammatory disorders, including rheumatoid arthritis and osteoarthritis, because increased numbers of MCs were found in patients suffering from these diseases. The clinical observations could be largely confirmed in experimental studies using MC-deficient mouse models, which also provide mechanistic insights. MCs also regulate bone healing after fracture by influencing the inflammatory response toward the fracture, vascularization, bone formation, and callus remodeling by osteoclasts. This review summarizes the current view and understanding of the role of MCs on bone in both physiological and pathological conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinician’s Guide to Prevention and Treatment of Osteoporosis
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., & Lindsay, R. (2014) · Osteoporosis International · doi:10.1007/s00198-014-2794-2 · Cited by 4,149
Osteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799 · cited 1×
“Mast cells (MCs) are tissue-resident immune cells and are best known for promoting allergic reactions (1).”
BackgroundT-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.
Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358
Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts
Azuma, Y., Kaji, K., Katogi, R., Takeshita, S., & Kudo, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4858 · Cited by 731
Cellular biology of fracture healing
Bahney, C. S., Zondervan, R. L., Allison, P., Theologis, A., Ashley, J. W., Ahn, J., Miclau, T., Marcucio, R. S., & Hankenson, K. D. (2019) · Journal of Orthopaedic Research · doi:10.1002/jor.24170 · Cited by 577
Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model
Alexander, K. A., Chang, M. K., Maylin, E. R., Kohler, T., Müller, R., Wu, A. C., Van Rooijen, N., Sweet, M. J., Hume, D. A., Raggatt, L. J., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.354 · Cited by 485
Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation
Montero, A., Okada, Y., Tomita, M., Ito, M., Tsurukami, H., Nakamura, T., Doetschman, T., Coffin, J. D., & Hurley, M. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8641 · Cited by 483
Mast cell tryptases and chymases in inflammation and host defense.
Caughey, G. H. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00509.x · Cited by 442 · cited 1×
“That is why their types and amounts of mediators can vary during MC maturation depending on the respective tissue (19).”
BackgroundTakai, H., Kanematsu, M., Yano, K., Tsuda, E., Higashio, K., Ikeda, K., Watanabe, K., & Yamada, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27091 · Cited by 299
Estradiol activates mast cells via a non-genomic estrogen receptor-α and calcium influx
Zaitsu, M., Narita, S.-I., Lambert, K. C., Grady, J. J., Estes, D. M., Curran, E. M., Brooks, E. G., Watson, C. S., Goldblum, R. M., & Midoro-Horiuti, T. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.030 · Cited by 262 · cited 2×
“For example, estrogen did not stimulate the degranulation of MCs derived from ERα knockout mice (134), indicating that estrogen is involved in MC activation via ERα signaling.”
BackgroundIshijima, M., Rittling, S. R., Yamashita, T., Tsuji, K., Kurosawa, H., Nifuji, A., Denhardt, D. T., & Noda, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.3.399 · Cited by 240
Fracture healing is accelerated in the absence of the adaptive immune system
Toben, D., Schroeder, I., El Khassawna, T., Mehta, M., Hoffmann, J.-E., Frisch, J.-T., Schell, H., Lienau, J., Serra, A., Radbruch, A., et al. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.185 · Cited by 236
IL-1 plays an important role in the bone metabolism under physiological conditions
Lee, Y.-M., Fujikado, N., Manaka, H., Yasuda, H., & Iwakura, Y. (2010) · International Immunology · doi:10.1093/intimm/dxq431 · Cited by 226
Innate Immunity and Its Regulation by Mast Cells
St. John, A. L., & Abraham, S. N. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203420 · Cited by 220
Crotti, T. N., Smith, M. D., Weedon, H., Ahern, M. J., Findlay, D. M., Kraan, M., Tak, P. P., & Haynes, D. R. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.12.1047 · Cited by 186
Jensen, F., Woudwyk, M., Teles, A., Woidacki, K., Taran, F., Costa, S., Malfertheiner, S. F., & Zenclussen, A. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014409 · Cited by 145 · cited 2×
“In agreement with this, estrogen treatment of the human MC line HMC-1 induced the de novo production of tryptase β1 and MC degranulation (135).”
BackgroundDistinct Effects of IL-6 Classic and Trans -Signaling in Bone Fracture Healing
Prystaz, K., Kaiser, K., Kovtun, A., Haffner-Luntzer, M., Fischer, V., Rapp, A. E., Liedert, A., Strauss, G., Waetzig, G. H., Rose-John, S., et al. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.10.011 · Cited by 142 · cited 1×
“↑ Bone formation (73, 74) ↑ Osteoclast formation and”
BackgroundSelf-citationKroner, J., Kovtun, A., Kemmler, J., Messmann, J. J., Strauss, G., Seitz, S., Schinke, T., Amling, M., Kotrba, J., Froebel, J., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3234 · Cited by 95
Self-citationESTROGEN REGULATES CYTOKINE RELEASE IN HUMAN MAST CELLS
Kim, M.-S., Chae, H.-J., Shin, T.-Y., Kim, H.-M., & Kim, H.-R. (2001) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-100108596 · Cited by 65 · cited 15×
“(C) In rheumatoid arthritis, increased MC numbers and concentrations of MC-mediators including histamine, tryptase, IL-6, and IL-17 are found in the inflamed joint, inducing osteoclastic bone resorption and T-cell driven inflammation.”
BackgroundInfluentialPrevalence and risk factors for fragility fracture in systemic mastocytosis
Degboé, Y., Eischen, M., Nigon, D., Apoil, P.-A., Mailhol, C., Tournier, E., Laurent, C., Hanssens, K., Hermine, O., Paul, C., et al. (2017) · Bone · doi:10.1016/j.bone.2017.09.005 · Cited by 44
Cited by
Interaction between bone and immune cells: Implications for postmenopausal osteoporosis
Fischer, V., & Haffner-Luntzer, M. (2022) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2021.05.014 · Cited by 759
Self-citationIantomasi, T., Romagnoli, C., Palmini, G., Donati, S., Falsetti, I., Miglietta, F., Aurilia, C., Marini, F., Giusti, F., & Brandi, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043772 · Cited by 380
Mast Cells Trigger Disturbed Bone Healing in Osteoporotic Mice
Fischer, V., Ragipoglu, D., Diedrich, J., Steppe, L., Dudeck, A., Schütze, K., Kalbitz, M., Gebhard, F., Haffner-Luntzer, M., & Ignatius, A. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4455 · Cited by 42
“catabolic (eg, histamine, IL-6, TNF, RANKL) and osteo-anabolic functions (eg, TGF-β, FGF), implying that mast cells contribute to the regulation of bone turnover in health and disease.((5-7))”
BackgroundSelf-citationBiomaterials-Driven Sterile Inflammation
Chen, H., Agrawal, D. K., & Thankam, F. G. (2022) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2020.0253 · Cited by 41
Zhao, S., Qiao, Z., Pfeifer, R., Pape, H.-C., Mao, K., Tang, H., Meng, B., Chen, S., & Liu, H. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01604-7 · Cited by 35
“Ragipoglu et al. speculated that the effect of mast cells on bone healing might be related to their recruitment of vascular endothelial cells and coordination of metabolic activities [59].”
Background
Metadata
- Authors
- Ragipoglu, D., Dudeck, A., Haffner-Luntzer, M., Voss, M., Kroner, J., Ignatius, A., & Fischer, V.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-02-07
- Volume
- 11
- Pages
- 163-163
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3005190156
- Cited by
- 105
- References
- 21
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.